Skip to main content

Advertisement

SpringerLink
Log in

Ophthalmic findings in myotonic dystrophy type 2: a case series

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Kersten HM, Roxburgh RH, Child N, Polkinghorne PJ, Frampton C, Danesh-Meyer HV (2014) Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1. J Neurol 261(1):37–44

    Article  PubMed  Google Scholar 

  2. Choi SH, Yang HK, Hwang JM, Park KS (2016) Ocular findings of myotonic dystrophy type 1 in the Korean population. Graefes Arch Clin Exp Ophthalmol 254(6):1189–1193

    Article  PubMed  Google Scholar 

  3. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254(5035):1178–1181

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293(5531):864–867

    Article  CAS  PubMed  Google Scholar 

  5. Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B (2011) Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet 19(7):776–782

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Finsterer J (2002) Myotonic dystrophy type 2. Eur J Neurol 9(5):441–447

    Article  CAS  PubMed  Google Scholar 

  7. Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P (2003) Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology 110(1):34–40

    Article  PubMed  Google Scholar 

  8. Watanabe A, Arimoto S, Nishi O (2009) Correlation between metamorphopsia and epiretinal membrane optical coherence tomography findings. Ophthalmology 116(9):1788–1793

    Article  PubMed  Google Scholar 

  9. Turner C, Hilton-Jones D (2010) The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81(4):358–367

    Article  PubMed  Google Scholar 

  10. Hayasaka S, Kiyosawa M, Katsumata S, Honda M, Takase S, Mizuno K (1984) Ciliary and retinal changes in myotonic dystrophy. Arch Ophthalmol 102(1):88–93

    Article  CAS  PubMed  Google Scholar 

  11. Kimizuka Y, Kiyosawa M, Tamai M, Takase S (1993) Retinal changes in myotonic dystrophy: clinical and follow-up evaluation. Retina 13(2):129–135

    Article  CAS  PubMed  Google Scholar 

  12. Rosa N, Lanza M, Borrelli M, De Bernardo M, Palladino A, Di Gregorio MG, Pascotto F, Politano L (2011) Low intraocular pressure resulting from ciliary body detachment in patients with myotonic dystrophy. Ophthalmology 118(2):260–264

    Article  PubMed  Google Scholar 

  13. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60(4):657–664

    Article  CAS  PubMed  Google Scholar 

  14. Ghazi-Nouri SMS, Tranos PG, Rubin GS, Adams ZC, Charteris DG (2006) Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br J Ophthalmol 90(5):559–562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Auckland, Private Bag 92019, Auckland, New Zealand

    Hannah M. Kersten & Helen V. Danesh-Meyer

  2. School of Optometry and Vision Science, University of Auckland, Private Bag 92019, Auckland, New Zealand

    Hannah M. Kersten

  3. Department of Neurology, Auckland City Hospital, Private Bag 92024, 2 Park Road, Auckland, 1023, New Zealand

    Richard H. Roxburgh

  4. Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, New Zealand

    Richard H. Roxburgh

Authors
  1. Hannah M. Kersten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen V. Danesh-Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard H. Roxburgh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard H. Roxburgh.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standards

This study has been approved by the appropriate ethics committees (Northern X (NTX/11/EXP/022) and ADHB Ethics Committees (A+5185)) and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants gave their informed consent prior to participation in this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kersten, H.M., Danesh-Meyer, H.V. & Roxburgh, R.H. Ophthalmic findings in myotonic dystrophy type 2: a case series. J Neurol 263, 2552–2554 (2016). https://doi.org/10.1007/s00415-016-8325-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-016-8325-7

Keywords

Search

Navigation